TC Biopharm (Holdings) Plc
TCBPY
$0.28
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.41M | 2.72M | 2.03M | 2.07M | 1.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 47.40K | 3.00K | -- | -- | 164.50K |
| Total Operating Expenses | 2.64M | 4.37M | 4.07M | 4.15M | 4.67M |
| Operating Income | -2.64M | -4.37M | -4.07M | -4.15M | -4.67M |
| Income Before Tax | -2.64M | -4.35M | -4.13M | -4.21M | 867.30K |
| Income Tax Expenses | -133.40K | -140.40K | -241.40K | -246.10K | -375.50K |
| Earnings from Continuing Operations | -2.51M | -4.21M | -3.89M | -3.96M | 1.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.51M | -4.21M | -3.89M | -3.96M | 1.24M |
| EBIT | -2.64M | -4.37M | -4.07M | -4.15M | -4.67M |
| EBITDA | -2.49M | -4.21M | -3.89M | -3.97M | -4.47M |
| EPS Basic | -402.30K | -- | -- | -- | -- |
| Normalized Basic EPS | -66.21 | -- | -- | -- | -- |
| EPS Diluted | -402.30K | -- | -- | -- | -- |
| Normalized Diluted EPS | -66.21 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 24.90K | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 0.00 | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |